Research Services Division

Deakin Research

Research Output for Rasika Samarasinghe

Note: The 2012, 2013, 2014 publications have not been audited.

Jump to: Publications | Grants and Consultancies | HDR completions


2012 School of Medicine

Samarasinghe, Rasika M, Kanwar, Rupinder K and Kanwar, Jagat R (2012) The role of nanomedicine in cell based therapeutics in cancer and inflammation., International journal of molecular and cellular medicine, vol. 1, no. 3, pp. 133-144, Babol University of Medical Sciences, Babol, Iran [C1.1]
ERA journal ID: Not matching ERA journal list
DRO entry for this publication

2012 Institute for Frontier Materials

Samarasinghe, Rasika M., Gibbons, Jessica, Kanwar, Rupinder K. and Kanwar, Jagat R. (2012) Nanotechnology based platforms for survivin targeted drug discovery, Expert opinion on drug discovery, vol. 7, no. 11, pp. 1083-1092, Informa Healthcare, London, England [C1]
ERA journal ID: Not matching ERA journal list
Citation counts: Thomson - 1
DRO entry for this publication

2012 BioDeakin

Kanwar, Jagat R., Samarasinghe, Rasika M., Sehgal, Rakesh* and Kanwar, Rupinder K. (2012) Nano-lactoferrin in diagnostic, imaging and targeted delivery for cancer and infectious diseases, Journal of cancer science & therapy, vol. 4, no. 3, pp. 31-42, OMICS Group, Westlake, Calif. [C1.1]
ERA journal ID: Not matching ERA journal list
Citation counts: Scopus - 3
DRO entry for this publication

Grants and Consultancies

No grants and/or consultancies found or audited – the 2014 HERDC financial return has not been completed or loaded as yet.

Higher Degree by Research Completions supervised by Rasika Samarasinghe

No completions found or audited.

* Not a member of Deakin University at time of output.

DRO to publications collection last synchronised: Wednesday 20th August 2014 10:04pm

Deakin University acknowledges the traditional land owners of present campus sites.

23rd July 2011